Pre-made Tinurilimab benchmark antibody ( Whole mAb, anti-CEACAM6/CD66c therapeutic antibody, Anti-CEAL/NCA Antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-ab-578
Pre-Made Tinurilimab biosimilar, Whole mAb, Anti-CEACAM6/CD66c Antibody: Anti-CEAL/NCA therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Tinurilimab (formerly BAY 1834942) is a humanised monoclonal antibody that selectively blocks the immune checkpoint regulator CEACAM6.
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Pre-Made Tinurilimab biosimilar, Whole mAb, Anti-CEACAM6/CD66c Antibody: Anti-CEAL/NCA therapeutic antibody|
|Highest_Clin_Trial (Jan '20)||Phase-I|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Bayer;German Cancer Research Center|
|Conditions Active||Solid tumours|